Daxor Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Daxor Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for Daxor were recently set by distinguished experts, with an average mark of $23.25. If it reached this goal, it would represent a potential upside of approximately 137.24% from the previous closing price in May, 2024. The high end is $24.50, and the low is $22.00. If you're considering investing in DXR stock, it's important to look at its competitors too.
137.24% Upside
Daxor Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Daxor's Price has grown from $0.00 to $0.00 – a 100.00% increase. Next year, analysts are expecting Fair Value to reach $0.00 – an increase of 100.00%. Over the next six years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$233.72 | Buy/Sell | $284.47 | 18.73% |
| ABMD Stock Forecast | Abiomed | - |
16
|
$377.79 | Buy/Sell | $380.00 | -88.33% |
| TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$211.54 | Buy/Sell | $263.46 | 25.27% |
| PEN Stock Forecast | Penumbra | Outperform |
9
|
$205.29 | Buy/Sell | $258.62 | 39.83% |
| GMED Stock Forecast | Globus Medical | Outperform |
16
|
$50.43 | Buy/Sell | $64.58 | 18.98% |
Daxor Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Daxor's Revenue has fallen from $260.00k to $230.00k – a 11.54% decrease. Next year, analysts are expecting Revenue to reach $257.86k – an increase of 12.11%. Over the next eight years, the forecast is for Revenue to grow by 13.06%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GKOS Stock Forecast | Glaukos | Outperform |
7
|
$98.91 | Buy/Sell | $87.33 | 8.18% |
| HAE Stock Forecast | Haemonetics | Outperform |
16
|
$92.13 | Buy/Sell | $70.17 | 13.97% |
| MMSI Stock Forecast | Merit Medical Systems | Outperform |
14
|
$76.63 | Buy/Sell | $89.25 | 14.84% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ICUI Stock Forecast | ICU Medical | Outperform |
16
|
$98.29 | Buy/Sell | $153.50 | 38.87% |
| NARI Stock Forecast | Inari Medical | Outperform |
14
|
$41.60 | Buy/Sell | $82.67 | 68.27% |
| NUVA Stock Forecast | NuVasive | - |
14
|
$4.86 | Buy/Sell | $73.81 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LMAT Stock Forecast | LeMaitre Vascular | Outperform |
18
|
$66.78 | Buy/Sell | $59.86 | 7.82% |
| APR Stock Forecast | Apria | - |
16
|
$37.50 | Buy/Sell | $37.50 | -100.00% |
| ATRC Stock Forecast | AtriCure | Buy |
8
|
$24.76 | Buy/Sell | $55.00 | 130.21% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ATRI Stock Forecast | Atrion | - |
18
|
$352.20 | Buy/Sell | $946.00 | -100.00% |
| IRMD Stock Forecast | IRadimed | Buy |
16
|
$42.00 | Buy/Sell | $60.00 | 48.81% |
| OFIX Stock Forecast | Orthofix Medical | Hold |
10
|
$13.03 | Buy/Sell | $18.00 | 15.12% |
Daxor EBIT Forecast for 2023 - 2025 - 2030
Daxor's EBIT has grown In the last two years, rising from $-340.00k to $-860.00k – a growth of 152.94%. According to 0 analysts, Daxor's EBIT will fall by 26.75% in the next year, reaching $-629.95k. Professionals believe that By 2030, Daxor's EBIT will fall to $-664.37k – a 22.75% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MON Stock Forecast | Misonix | - |
7
|
$26.54 | Buy/Sell | $28.00 | -100.00% |
| LYRA Stock Forecast | Lyra Therapeutics | Buy |
4
|
$5.25 | Buy/Sell | $11.80 | 128.57% |
| LUNG Stock Forecast | Pulmonx | Outperform |
4
|
$7.72 | Buy/Sell | $15.33 | 120.21% |
Daxor EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Daxor's EPS has grown from $-0.42 to $0.00 – a 100.00% increase. Next year, analysts are expecting EPS to reach $0.00 – an increase of 100.00%. Over the next six years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SGHT Stock Forecast | Sight Sciences | Hold |
5
|
$5.59 | Buy/Sell | $3.88 | -6.08% |
| APEN Stock Forecast | Apollo Endosurgery | - |
10
|
$10.00 | Buy/Sell | $0.00 | -100.00% |
| ANGO Stock Forecast | AngioDynamics | Buy |
8
|
$5.79 | Buy/Sell | $16.33 | 124.53% |
.jpg)